Evidence map›Paper›PMID 31948131›Full record

ReviewInternational journal of molecular sciences2020

Oxidative Stress-Responsive MicroRNAs in Heart Injury.

Branislav Kura, Barbara Szeiffova Bacova, Barbora Kalocayova, Matus Sykora, Jan Slezak

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 1 synthesis or guideline pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Contrasting the genetic architecture of cardiac glutathione against other organs: unveiling a unique tissue-specific locus.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  6. Article
  7. MiR-21 modulatesNon-coding RNA research · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Nrf2 signaling pathway: focus on oxidative stress in osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Review
  12. Article
  13. Fibroblasts-specific p16Clinical and translational medicine · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Frontiers in pharmacology · 2025
    Review
  18. Iranian journal of basic medical sciences · 2025
    Article
  19. Oxidative Stress in Cardiovascular Diseases: Mechanisms and Exploring Advanced Therapies.Cardiovascular & hematological agents in medicinal chemistry · 2025
    Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Branislav KuraCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0001-6743-491X
Barbara Szeiffova BacovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.
Barbora KalocayovaCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0002-5283-7561
Matus SykoraCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0002-0438-3956
Jan SlezakCentre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia.ORCID 0000-0002-4217-4493
Slovak Academy of Sciences · SK

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-15-0376European Union Structural funds ITMS 26230120009Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 2/0021/15Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 2/0063/18Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 2/0158/19Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 2/0166/17
6 · The paper itself

Abstract

Reactive oxygen species (ROS) are important molecules in the living organisms as a part of many signaling pathways. However, if overproduced, they also play a significant role in the development of cardiovascular diseases, such as arrhythmia, cardiomyopathy, ischemia/reperfusion injury (e.g., myocardial infarction and heart transplantation), and heart failure. As a result of oxidative stress action, apoptosis, hypertrophy, and fibrosis may occur. MicroRNAs (miRNAs) represent important endogenous nucleotides that regulate many biological processes, including those involved in heart damage caused by oxidative stress. Oxidative stress can alter the expression level of many miRNAs. These changes in miRNA expression occur mainly via modulation of nuclear factor erythroid 2-related factor 2 (Nrf2), sirtuins, calcineurin/nuclear factor of activated T cell (NFAT), or nuclear factor kappa B (NF-κB) pathways. Up until now, several circulating miRNAs have been reported to be potential biomarkers of ROS-related cardiac diseases, including myocardial infarction, hypertrophy, ischemia/reperfusion, and heart failure, such as miRNA-499, miRNA-199, miRNA-21, miRNA-144, miRNA-208a, miRNA-34a, etc. On the other hand, a lot of studies are aimed at using miRNAs for therapeutic purposes. This review points to the need for studying the role of redox-sensitive miRNAs, to identify more effective biomarkers and develop better therapeutic targets for oxidative-stress-related heart diseases.

Indexed as

AnimalsCardiomegalyCoronary Artery DiseaseHeart FailureHumansMicroRNAsMyocardial Reperfusion InjuryNF-E2-Related Factor 2NF-kappa BOxidative StressReactive Oxygen SpeciesSirtuin 1MicroRNAsNF-E2-Related Factor 2NF-kappa BReactive Oxygen SpeciesSirtuin 1cardiovascular diseasesischemia/reperfusion injurymiRNAoxidative stresstransplantation

Identifiers

PMID31948131
PMCPMC6981696
OpenAlexW2996769041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.